• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿眼部检查后出现房性心律失常,用咖啡因还是不用咖啡因?

Atrial arrhythmia after newborn eye exam, to caffeine or not to caffeine?

作者信息

Ahmad A, Mondal T, Klein B

机构信息

Department of Pediatrics, McMaster University, ON, Canada.

Department of Pediatrics Cardiology, McMaster University, ON, Canada.

出版信息

J Neonatal Perinatal Med. 2016;9(4):427-431. doi: 10.3233/NPM-160167.

DOI:10.3233/NPM-160167
PMID:28009338
Abstract

Mydriatic drops are routinely administered to premature neonates to screen for retinopathy of prematurity. Adverse anticholinergic side effects, particularly convulsions and tachycardia have been reported in the pediatric age group following instillation of mydriatics for diagnostic fundus examination [1, 2]. Caffeine is frequently used for apnea of prematurity. In the neonatal intensive care unit, the combined use of caffeine and mydriatic drops is a common practice. Here we report two cases of atrial arrhythmias after neonatal eye exam that improved with conservative management. Both patients were receiving caffeine at the time of events.

摘要

常规给早产儿使用散瞳滴眼液以筛查早产儿视网膜病变。在儿科年龄组中,为进行诊断性眼底检查滴入散瞳剂后,已有抗胆碱能副作用的报道,尤其是惊厥和心动过速[1,2]。咖啡因常用于治疗早产儿呼吸暂停。在新生儿重症监护病房,联合使用咖啡因和散瞳滴眼液是常见的做法。在此,我们报告两例新生儿眼部检查后出现房性心律失常的病例,经保守治疗后病情好转。两名患者在发病时均正在使用咖啡因。

相似文献

1
Atrial arrhythmia after newborn eye exam, to caffeine or not to caffeine?新生儿眼部检查后出现房性心律失常,用咖啡因还是不用咖啡因?
J Neonatal Perinatal Med. 2016;9(4):427-431. doi: 10.3233/NPM-160167.
2
Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates.随机对照初步试验比较小剂量和极低剂量苯肾上腺素和环戊通微滴给药用于早产儿视网膜病变检查
Arch Dis Child. 2021 Jun;106(6):603-608. doi: 10.1136/archdischild-2019-318733. Epub 2020 Oct 13.
3
Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity.早产儿视网膜病变筛查期间使用环喷托酯-去氧肾上腺素滴眼液后出现的短暂性麻痹性肠梗阻。
J Paediatr Child Health. 2003 May-Jun;39(4):318-20. doi: 10.1046/j.1440-1754.2003.00144.x.
4
Fatal necrotising enterocolitis due to mydriatic eye drops.散瞳眼药水导致的致命性坏死性小肠结肠炎。
J Coll Physicians Surg Pak. 2014 May;24 Suppl 2:S147-9.
5
A Survey of Neonatal Nurses on Mydriatic Regimens Used in Neonatal Retinopathy of Prematurity Eye Examinations.新生儿护士对早产儿视网膜病变眼科检查中使用的散瞳方案的调查。
Am J Perinatol. 2022 Dec;39(16):1779-1785. doi: 10.1055/s-0041-1726316. Epub 2021 Mar 30.
6
Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.一名早产新生儿使用散瞳剂后并发急性胃扩张。
Pediatr Radiol. 2001 Aug;31(8):581-3. doi: 10.1007/s002470100498.
7
Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening.门诊早产儿视网膜病变筛查时使用环孢霉素眼药水后发生心肺骤停。
J AAPOS. 2014 Apr;18(2):183-4. doi: 10.1016/j.jaapos.2013.11.010.
8
[Serious adverse side effects after pupillary dilation in preterm infants].[早产儿瞳孔散大后的严重不良副作用]
J Fr Ophtalmol. 2015 Mar;38(3):193-8. doi: 10.1016/j.jfo.2014.10.008. Epub 2015 Feb 25.
9
Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.早产儿视网膜病变检查后环喷托酯的全身吸收及不良事件
Curr Eye Res. 2016 Dec;41(12):1601-1607. doi: 10.3109/02713683.2015.1136419. Epub 2016 May 9.
10
The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.婴儿滴入散瞳眼药水后局部皮肤血管收缩。
Eur J Clin Pharmacol. 2010 Nov;66(11):1161-4. doi: 10.1007/s00228-010-0890-6. Epub 2010 Sep 11.

引用本文的文献

1
Systematic review of mydriatics used for screening of retinopathy in premature infants.用于筛查早产儿视网膜病变的散瞳剂的系统评价
BMJ Paediatr Open. 2019 May 9;3(1):e000448. doi: 10.1136/bmjpo-2019-000448. eCollection 2019.